EUCOPE News by Category — News

Filtered by Category: News

Member Spotlight / News - October 28, 2022

EUCOPE Member Spotlight: Q&A with Grifols

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Cesar Rubio, Associate Director, Government and Public Affairs, Grifols. César Rubio is Associate Director,… read more

EUCOPE Resources / News / Press Releases - October 26, 2022

EUCOPE/EFPIA Joint Statement: Concerns over the implementation of the EU HTA Regulation

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA experts and… read more

News - October 18, 2022

Event Recap – TRANSFORM Alliance Charter Launch (13 October 2022)

EUCOPE discusses solutions across the R&D lifecycle to build a European system fit for transformative therapies On the 13th of October 2022, the European Alliance for Transformative Therapies (TRANSFORM) came together with the MEP Interest Group to launch an MEP Charter in the European Parliament…. read more

EUCOPE Resources / News - October 13, 2022

🎙️Sounds of Science Episode 9 on ATMPs

Sounds of Science Podcast – Episode 9 Advanced Therapy Medicinal Products (ATMPs): How they will be impacted by the General Pharmaceutical Legislation On our latest episode, we explore the topic of Advanced Therapy Medical Products, or ATMPs. This covers a wide range of therapies, but… read more

News - July 28, 2022

On the update of the Blood, Tissues and Cell (BTC) Legislation

On July 14, the European Commission formally published its proposal updating the BTC legislation. Under the Commission’s proposal, the two Directives (2002/98/EC, for blood and blood components and 2004/23/EC, for tissues and cells) will be rolled into one Regulation, the SoHO (Substances of Human Origin) Regulation…. read more